Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07461207) titled 'A Translational Study to Explore and Overcome Metabolic-driven Resistance Mechanisms to Standard Chemotherapy in High-grade Ovarian Cancer' on March 5.

Study Type: Observational

Primary Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Condition: High-grade Serous Ovarian Carcinoma (HGSOC)

Recruitment Status: Not recruiting

Date of First Enrollment: March 2026

Target Sample Size: 120

Countries of Recruitment: Italy

To know more, visit https://clinicaltrials.gov/study/NCT07461207

Published by HT Digital Content Services with permission from Health Daily Digest....